Bradmer Pharmaceuticals (TSE:GLX) Issues Earnings Results

Bradmer Pharmaceuticals (TSE:GLXGet Free Report) issued its quarterly earnings data on Tuesday. The company reported C$1.11 EPS for the quarter, reports.

Bradmer Pharmaceuticals Stock Performance

Analysts Set New Price Targets

Separately, Stifel Canada reaffirmed a “buy” rating on shares of Bradmer Pharmaceuticals in a report on Wednesday, March 13th.

Read Our Latest Report on Bradmer Pharmaceuticals

Recommended Stories

Earnings History for Bradmer Pharmaceuticals (TSE:GLX)

Receive News & Ratings for Bradmer Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bradmer Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.